Your browser doesn't support javascript.
loading
Kinase inhibitors for cancer alter metabolism, blood glucose, and insulin.
Duggan, Brittany M; Marko, Daniel M; Muzaffar, Raveen; Chan, Darryl Y; Schertzer, Jonathan D.
Afiliação
  • Duggan BM; 1Department of Biochemistry and Biomedical Sciences, Farncombe Family Digestive Health Research Institute, and Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada.
  • Marko DM; 1Department of Biochemistry and Biomedical Sciences, Farncombe Family Digestive Health Research Institute, and Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada.
  • Muzaffar R; 1Department of Biochemistry and Biomedical Sciences, Farncombe Family Digestive Health Research Institute, and Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada.
  • Chan DY; 1Department of Biochemistry and Biomedical Sciences, Farncombe Family Digestive Health Research Institute, and Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada.
  • Schertzer JD; 1Department of Biochemistry and Biomedical Sciences, Farncombe Family Digestive Health Research Institute, and Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada.
J Endocrinol ; 256(2)2023 02 01.
Article em En | MEDLINE | ID: mdl-36476560

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Inibidores de Proteínas Quinases / Diabetes Mellitus Tipo 1 / Diabetes Mellitus Tipo 2 / Neoplasias Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Inibidores de Proteínas Quinases / Diabetes Mellitus Tipo 1 / Diabetes Mellitus Tipo 2 / Neoplasias Idioma: En Ano de publicação: 2023 Tipo de documento: Article